160 related articles for article (PubMed ID: 24258854)
1. Prognosis of patients with melanoma and microsatellitosis undergoing sentinel lymph node biopsy.
Bartlett EK; Gupta M; Datta J; Gimotty PA; Guerry D; Xu X; Elder DE; Czerniecki BJ; Fraker DL; Karakousis GC
Ann Surg Oncol; 2014 Mar; 21(3):1016-23. PubMed ID: 24258854
[TBL] [Abstract][Full Text] [Related]
2. Microsatellitosis in Patients with Melanoma.
Karakousis GC; Gimotty PA; Leong SP; Pockaj BA; White RL; O'Donoghue C; Sinnamon AJ; Bartlett EK; Dueck AC; Gould Rothberg BE; Messina JL; Vetto JT; Sondak VK; Schneebaum S; Kashani-Sabet M; Han D; Faries MB; Zager JS;
Ann Surg Oncol; 2019 Jan; 26(1):33-41. PubMed ID: 30421045
[TBL] [Abstract][Full Text] [Related]
3. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
4. Identification of Patients with Intermediate Thickness Melanoma at Low Risk for Sentinel Lymph Node Positivity.
Bartlett EK; Peters MG; Blair A; Etherington MS; Elder DE; Xu XG; Guerry D; Ming ME; Fraker DL; Czerniecki BJ; Gimotty PA; Karakousis GC
Ann Surg Oncol; 2016 Jan; 23(1):250-6. PubMed ID: 26215202
[TBL] [Abstract][Full Text] [Related]
5. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
[TBL] [Abstract][Full Text] [Related]
8. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
9. Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.
Tejera-Vaquerizo A; Ribero S; Puig S; Boada A; Paradela S; Moreno-Ramírez D; Cañueto J; de Unamuno B; Brinca A; Descalzo-Gallego MA; Osella-Abate S; Cassoni P; Carrera C; Vidal-Sicart S; Bennássar A; Rull R; Alos L; Requena C; Bolumar I; Traves V; Pla Á; Fernández-Orland A; Jaka A; Fernández-Figueres MT; Hilari JM; Giménez-Xavier P; Vieira R; Botella-Estrada R; Román-Curto C; Ferrándiz L; Iglesias-Pena N; Ferrándiz C; Malvehy J; Quaglino P; Nagore E;
Cancer Med; 2019 Aug; 8(9):4235-4244. PubMed ID: 31215168
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.
Bello DM; Han G; Jackson L; Bulloch K; Ariyan S; Narayan D; Rothberg BG; Han D
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):938-945. PubMed ID: 27527717
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of Melanoma After a Negative Sentinel Node Biopsy: Predictors and Impact of Recurrence Site on Survival.
Thomas DC; Han G; Leong SP; Kashani-Sabet M; Vetto J; Pockaj B; White RL; Faries MB; Schneebaum S; Mozzillo N; Charney KJ; Sondak VK; Messina JL; Zager JS; Han D
Ann Surg Oncol; 2019 Jul; 26(7):2254-2262. PubMed ID: 31011906
[TBL] [Abstract][Full Text] [Related]
12. Observation after a positive sentinel lymph node biopsy in patients with melanoma.
Bamboat ZM; Konstantinidis IT; Kuk D; Ariyan CE; Brady MS; Coit DG
Ann Surg Oncol; 2014 Sep; 21(9):3117-23. PubMed ID: 24833100
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with false-negative sentinel lymph node biopsy in melanoma patients.
Scoggins CR; Martin RC; Ross MI; Edwards MJ; Reintgen DS; Urist MM; Gershenwald JE; Sussman JJ; Dirk Noyes R; Goydos JS; Beitsch PD; Ariyan S; Stromberg AJ; Hagendoorn LJ; McMasters KM
Ann Surg Oncol; 2010 Mar; 17(3):709-17. PubMed ID: 19967459
[TBL] [Abstract][Full Text] [Related]
14. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.
Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C
Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center.
Namikawa K; Aung PP; Gershenwald JE; Milton DR; Prieto VG
Cancer Med; 2018 Mar; 7(3):583-593. PubMed ID: 29464914
[TBL] [Abstract][Full Text] [Related]
16. Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role?
Ribero S; Osella-Abate S; Sanlorenzo M; Balagna E; Senetta R; Fierro MT; Macripò G; Macrì L; Sapino A; Quaglino P
Ann Surg Oncol; 2015; 22(6):1967-73. PubMed ID: 25388059
[TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
[TBL] [Abstract][Full Text] [Related]
18. Incomplete sentinel node biopsy is not clearly related to survival or regional recurrence in cutaneous melanoma patients.
Lee NC; Spillane AJ; Pang TC; Haydu LE; Uren RF
Ann Surg Oncol; 2012 Jan; 19(1):280-6. PubMed ID: 21833669
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
[TBL] [Abstract][Full Text] [Related]
20. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.
Conic RRZ; Ko J; Damiani G; Funchain P; Knackstedt T; Vij A; Vidimos A; Gastman BR
J Am Acad Dermatol; 2019 Feb; 80(2):441-447. PubMed ID: 30240775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
